|
|
Article: Appointments And Advancements.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Celldex Therapeutics, of Phillipsburg, N.J., appointed Ronald Newbold vice president of business development, and Robert Forbes Burns CEO.
Cephalon Inc., of Frazer, Pa., appointed Kevin Moley to its board.
ChondroGene Ltd., of Toronto, appointed David Tyler director, product development and quality assurance.
ConjuChem Inc., of Montreal, appointed Thomas Ulich executive vice president, research and development.
Esbatech AG, of Zurich, Switzerland, appointed James Egan chief business officer.
Foley & Lardner LLP, of Boston, appointed Sven Riethmueller a member of its business law department and life sciences and emerging ...